Memantina Camriz

Memantine Hydrochloride, the active ingredient in Memantina Camriz, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is used to treat cognitive symptoms of Alzheimer’s disease in adults.

GNH USA supplies Memantina Camriz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantina Camriz is a NMDA receptor antagonist indicated for the treatment of Alzheimer’s disease and related symptoms.

- Alzheimer's disease (moderate to severe): improves cognition, memory and daily functioning. - Alzheimer's disease (mild to moderate): may provide modest cognitive benefit and delay functional decline. - Behavioral symptoms in Alzheimer’s disease: can reduce agitation and aggression in some patients.

Memantina Camriz may cause a range of adverse reactions. The most frequently reported events are generally mild and reversible.

Common Side Effects: - Dizziness: transient light‑headedness, especially on standing. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Fatigue: feeling of tiredness or lack of energy. - Nausea: occasional upset stomach. - Confusion: temporary disorientation.

Serious or Rare Side Effects: - Seizures: rare occurrence of convulsive episodes. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hallucinations: visual or auditory disturbances. - Hypertension: unexpected rise in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy with Memantina Camriz, consider the following safety measures.

- Renal impairment: adjust dose or monitor renal function. - Hepatic disease: use with caution and monitor liver enzymes. - Concomitant CNS depressants: assess for additive sedation. - History of seizures: evaluate risk versus benefit. - Pregnancy and breastfeeding: avoid unless clearly needed. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Memantina Camriz can interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Amantadine: may increase risk of neurotoxicity. - NMDA agonists: antagonistic effect may reduce therapeutic benefit. - Strong CYP3A4 inducers: may lower memantine plasma levels.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen cognitive side effects. - CNS depressants (e.g., benzodiazepines): monitor for enhanced sedation. - Diuretics: watch for electrolyte disturbances. - Antihypertensives: possible additive blood pressure effects.